Literature DB >> 23793952

Topographic regulation of neuronal intermediate filaments by phosphorylation, role of peptidyl-prolyl isomerase 1: significance in neurodegeneration.

B K Binukumar1, Varsha Shukla, Niranjana D Amin, Preethi Reddy, Suzanne Skuntz, Philip Grant, Harish C Pant.   

Abstract

The neuronal cytoskeleton is tightly regulated by phosphorylation and dephosphorylation reactions mediated by numerous associated kinases, phosphatases and their regulators. Defects in the relative kinase and phosphatase activities and/or deregulation of compartment-specific phosphorylation result in neurodegenerative disorders. The largest family of cytoskeletal proteins in mammalian cells is the superfamily of intermediate filaments (IFs). The neurofilament (NF) proteins are the major IFs. Aggregated forms of hyperphosphorylated tau and phosphorylated NFs are found in pathological cell body accumulations in the central nervous system of patients suffering from Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis. The precise mechanisms for this compartment-specific phosphorylation of cytoskeletal proteins are not completely understood. In this review, we focus on the mechanisms of neurofilament phosphorylation in normal physiology and neurodegenerative diseases. We also address the recent breakthroughs in our understanding the role of different kinases and phosphatases involved in regulating the phosphorylation status of the NFs. In addition, special emphasis has been given to describe the role of phosphatases and Pin1 in phosphorylation of NFs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793952     DOI: 10.1007/s00418-013-1108-7

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  72 in total

1.  Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments.

Authors:  Q Zhu; S Couillard-Després; J P Julien
Journal:  Exp Neurol       Date:  1997-11       Impact factor: 5.330

2.  Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus.

Authors:  Max Holzer; Ulrich Gärtner; Andrea Stöbe; Wolfgang Härtig; Hildegard Gruschka; Martina K Brückner; Thomas Arendt
Journal:  Acta Neuropathol       Date:  2002-07-03       Impact factor: 17.088

3.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.

Authors:  P J Lu; G Wulf; X Z Zhou; P Davies; K P Lu
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

4.  Different proteins associated with 10-nanometer filaments in cultured chick neurons and nonneuronal cells.

Authors:  G S Bennett; S J Tapscott; F A Kleinbart; P B Antin; H Holtzer
Journal:  Science       Date:  1981-05-01       Impact factor: 47.728

5.  Axonal damage markers in cerebrospinal fluid are increased in ALS.

Authors:  J Brettschneider; A Petzold; S D Süssmuth; A C Ludolph; H Tumani
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

Review 6.  Neuronal intermediate filaments: new progress on an old subject.

Authors:  Z Xu; D L Dong; D W Cleveland
Journal:  Curr Opin Neurobiol       Date:  1994-10       Impact factor: 6.627

7.  Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins.

Authors:  Jie Zhou; Hongxing Wang; Youmei Feng; Juan Chen
Journal:  Life Sci       Date:  2010-02-12       Impact factor: 5.037

8.  Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit.

Authors:  B I Giasson; W E Mushynski
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

9.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease.

Authors:  Z Xu; L C Cork; J W Griffin; D W Cleveland
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

10.  Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression.

Authors:  M Tortarolo; P Veglianese; N Calvaresi; A Botturi; C Rossi; A Giorgini; A Migheli; C Bendotti
Journal:  Mol Cell Neurosci       Date:  2003-06       Impact factor: 4.314

View more
  7 in total

1.  In focus in Prague: intermediate filaments.

Authors:  Jürgen Roth; Paul Debbage; Pavel Hozák
Journal:  Histochem Cell Biol       Date:  2013-06-07       Impact factor: 4.304

Review 2.  The Histochem Cell Biol conspectus: the year 2013 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2014-03-09       Impact factor: 4.304

Review 3.  Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Authors:  Natasha T Snider; M Bishr Omary
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

Review 4.  Dynamic self-guiding analysis of Alzheimer's disease.

Authors:  Alexei Kurakin; Dale E Bredesen
Journal:  Oncotarget       Date:  2015-06-10

5.  Zika Virus Infection Leads to Demyelination and Axonal Injury in Mature CNS Cultures.

Authors:  Verena Schultz; Stephanie L Cumberworth; Quan Gu; Natasha Johnson; Claire L Donald; George A McCanney; Jennifer A Barrie; Ana Da Silva Filipe; Christopher Linington; Hugh J Willison; Julia M Edgar; Susan C Barnett; Alain Kohl
Journal:  Viruses       Date:  2021-01-11       Impact factor: 5.048

6.  Analysis of the Inhibitory Elements in the p5 Peptide Fragment of the CDK5 Activator, p35, CDKR1 Protein.

Authors:  B K Binukumar; Varsha Shukla; Niranjana D Amin; Manju Bhaskar; Suzanne Skuntz; Joseph Steiner; Dirk Winkler; Steven L Pelech; Harish C Pant
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Phosphorylation, Dephosphorylation, and Multiprotein Assemblies Regulate Dynamic Behavior of Neuronal Cytoskeleton: A Mini-Review.

Authors:  Natalya Kurochkina; Manju Bhaskar; Sharda Prasad Yadav; Harish C Pant
Journal:  Front Mol Neurosci       Date:  2018-10-08       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.